psychiatric drugs

Brain and money connected by a thread on a white background

AbbVie makes Richter richer, paying $25M to form discovery pact

AbbVie has returned to the source of its antipsychotic powerhouse Vrayla, paying $25 million upfront to form a new discovery pact with Gedeon Richter.

Nick Paul Taylor Oct 25, 2024 7:55am

AbbVie pens $2B-plus neuro pact with Gilgamesh

May 13, 2024 5:57pm

A concept image to illustrate mental health medications Models of a pink brain and two white pills which are about the size

Headlands acquires Pharmasite to expand mental health trials

Feb 29, 2024 4:20pm

Alto Neuroscience preps IPO to push CNS therapies through clinic

Jan 16, 2024 6:51am

alzheimers brain neurodegenerative memory mental health

Oryzon med fails to improve borderline personality disorder

Jan 7, 2024 4:17pm

MA strategy deal block push come together form

AbbVie pads neuroscience portfolio with $8.7B Cerevel deal

Dec 6, 2023 5:19pm